Roles of motility, chemotaxis, and penetration through and growth in intestinal mucus in the ability of an avirulent strain of Salmonella typhimurium to colonize the large intestine of streptomycin-treated mice.

PubWeight™: 1.81‹?› | Rank: Top 3%

🔗 View Article (PMC 259551)

Published in Infect Immun on September 01, 1988

Authors

B A McCormick1, B A Stocker, D C Laux, P S Cohen

Author Affiliations

1: Department of Microbiology, University of Rhode Island, Kingston 02881.

Articles citing this

Cognate gene clusters govern invasion of host epithelial cells by Salmonella typhimurium and Shigella flexneri. EMBO J (1993) 4.64

Salmonella typhimurium mutants lacking flagella or motility remain virulent in BALB/c mice. Infect Immun (1990) 1.93

Type 1 pili are not necessary for colonization of the streptomycin-treated mouse large intestine by type 1-piliated Escherichia coli F-18 and E. coli K-12. Infect Immun (1989) 1.81

Role of lipopolysaccharide in colonization of the mouse intestine by Salmonella typhimurium studied by in situ hybridization. Infect Immun (1996) 1.74

Host-bacterial symbiosis in health and disease. Adv Immunol (2010) 1.73

An Escherichia coli MG1655 lipopolysaccharide deep-rough core mutant grows and survives in mouse cecal mucus but fails to colonize the mouse large intestine. Infect Immun (2003) 1.71

Intestinal colonization potential of turbot (Scophthalmus maximus)- and dab (Limanda limanda)-associated bacteria with inhibitory effects against Vibrio anguillarum. Appl Environ Microbiol (1992) 1.53

Mouse intestine selects nonmotile flhDC mutants of Escherichia coli MG1655 with increased colonizing ability and better utilization of carbon sources. Infect Immun (2005) 1.43

Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system. Appl Environ Microbiol (2005) 1.36

Salmonella pathogenesis and processing of secreted effectors by caspase-3. Science (2010) 1.25

Questions about the behaviour of bacterial pathogens in vivo. Philos Trans R Soc Lond B Biol Sci (2000) 1.22

rpoS gene function is a disadvantage for Escherichia coli BJ4 during competitive colonization of the mouse large intestine. Infect Immun (2000) 1.22

The blessings and curses of intestinal inflammation. Cell Host Microbe (2010) 1.20

Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents. Clin Microbiol Rev (2014) 1.17

L-fucose stimulates utilization of D-ribose by Escherichia coli MG1655 DeltafucAO and E. coli Nissle 1917 DeltafucAO mutants in the mouse intestine and in M9 minimal medium. Infect Immun (2007) 1.17

Phosphatidylserine found in intestinal mucus serves as a sole source of carbon and nitrogen for salmonellae and Escherichia coli. Infect Immun (1992) 1.14

Near surface swimming of Salmonella Typhimurium explains target-site selection and cooperative invasion. PLoS Pathog (2012) 1.10

Salmonella Interaction with and Passage through the Intestinal Mucosa: Through the Lens of the Organism. Front Microbiol (2011) 1.04

Isolation of nonchemotactic mutants of Campylobacter jejuni and their colonization of the mouse intestinal tract. Infect Immun (1992) 1.03

Growth in and breakdown of purified rabbit small intestinal mucin by Yersinia enterocolitica. Infect Immun (1993) 0.97

A functional cra gene is required for Salmonella enterica serovar typhimurium virulence in BALB/c mice. Infect Immun (2000) 0.94

Neither motility nor chemotaxis plays a role in the ability of Escherichia coli F-18 to colonize the streptomycin-treated mouse large intestine. Infect Immun (1990) 0.94

Intestinal innate immunity and the pathogenesis of Salmonella enteritis. Immunol Res (2007) 0.93

Salmonella choleraesuis strains deficient in O antigen remain fully virulent for mice by parenteral inoculation but are avirulent by oral administration. Infect Immun (1990) 0.91

Role of deoxyribose catabolism in colonization of the murine intestine by pathogenic Escherichia coli strains. Infect Immun (2009) 0.91

Commensal and Pathogenic Escherichia coli Metabolism in the Gut. Microbiol Spectr (2015) 0.90

Characterization of the properties of human- and dairy-derived probiotics for prevention of infectious diseases in fish. Appl Environ Microbiol (2001) 0.89

Bacterial flagella: twist and stick, or dodge across the kingdoms. PLoS Pathog (2015) 0.85

Growth of Escherichia coli K88 in piglet ileal mucus: protein expression as an indicator of type of metabolism. J Bacteriol (1995) 0.80

Microbial biofilms and gastrointestinal diseases. Pathog Dis (2013) 0.79

Pathogenic E. coli exploits SslE mucinase activity to translocate through the mucosal barrier and get access to host cells. PLoS One (2015) 0.79

The Serine Protease Autotransporter Pic Modulates Citrobacter rodentium Pathogenesis and Its Innate Recognition by the Host. Infect Immun (2015) 0.79

Adhesion of vancomycin-resistant enterococcus to human intestinal mucus. Curr Microbiol (2006) 0.78

Interaction between host cells and septicemic Salmonella enterica serovar typhimurium isolates from pigs. J Clin Microbiol (2009) 0.75

Articles cited by this

Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature (1981) 19.90

Phage P22-mutants with increased or decreased transduction abilities. Mol Gen Genet (1972) 10.34

Intestinal epithelial cell surface membrane glycoprotein synthesis. I. An indicator of cellular differentiation. J Biol Chem (1973) 6.99

Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vivo studies. Infect Immun (1981) 4.34

RESISTANCE OF THE MOUSE'S INTESTINAL TRACT TO EXPERIMENTAL SALMONELLA INFECTION. II. FACTORS RESPONSIBLE FOR ITS LOSS FOLLOWING STREPTOMYCIN TREATMENT. J Exp Med (1964) 3.80

Survival and implantation of Escherichia coli in the intestinal tract. Infect Immun (1983) 3.49

Restriction of nonglucosylated T-even bacteriophage: properties of permissive mutants of Escherichia coli B and K12. Virology (1967) 3.30

Salmonella typhimurium mutants generally defective in chemotaxis. J Bacteriol (1976) 3.10

A new biotyping scheme for Salmonella typhimurium and its phylogenetic significance. J Med Microbiol (1975) 3.00

Effects of galU mutation on flagellar formation in Escherichia coli. J Bacteriol (1977) 2.93

Mechanisms that control bacterial populations in continuous-flow culture models of mouse large intestinal flora. Infect Immun (1983) 2.88

Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vitro studies. Infect Immun (1981) 2.76

Bacterial degradation of gastrointestinal mucins. I. Comparison of mucus constituents in the stools of germ-free and conventional rats. Gastroenterology (1968) 2.17

Adhesion of a human fecal Escherichia coli strain to mouse colonic mucus. Infect Immun (1985) 2.07

Flagella help Salmonella typhimurium survive within murine macrophages. Infect Immun (1984) 1.95

Colonization of the mouse intestine by an avirulent Salmonella typhimurium strain and its lipopolysaccharide-defective mutants. Infect Immun (1985) 1.83

Factors responsible for increased susceptibility of mice to intestinal colonization after treatment with streptomycin. Infect Immun (1986) 1.71

Identification and characterization of mouse small intestine mucosal receptors for Escherichia coli K-12(K88ab). Infect Immun (1986) 1.47

In vivo colonization of the mouse large intestine and in vitro penetration of intestinal mucus by an avirulent smooth strain of Salmonella typhimurium and its lipopolysaccharide-deficient mutant. Infect Immun (1987) 1.36

Cholesterol lowering, fecal bile acid, and sterol changes during neomycin and colchicine. Am J Clin Nutr (1970) 1.10

Articles by these authors

Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature (1981) 19.90

Non-smooth mutants of Salmonella typhimurium: differentiation by phage sensitivity and genetic mapping. J Gen Microbiol (1972) 8.09

Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans. Crit Care Med (1997) 4.01

Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. Cancer Res (1984) 3.67

Identification and characterization of TnphoA mutants of Salmonella that are unable to pass through a polarized MDCK epithelial cell monolayer. Mol Microbiol (1988) 3.59

Complementation of non-flagellate Salmonella mutants. J Gen Microbiol (1965) 3.36

Salmonella typhimurium mutants generally defective in chemotaxis. J Bacteriol (1976) 3.10

Ribosomes exist in large excess over the apparent demand for protein synthesis during carbon starvation in marine Vibrio sp. strain CCUG 15956. J Bacteriol (1992) 3.07

Immune response to cholera toxin epitope inserted in Salmonella flagellin. Science (1989) 2.83

A new fla gene in Salmonella typhimurium--flaR--and its mutant phenotype-superhooks. Arch Mikrobiol (1973) 2.80

Transduction by bacteriophage P22 in nonsmooth mutants of Salmonella typhimurium. J Bacteriol (1967) 2.78

Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium. Microb Pathog (1987) 2.66

Nonsense motility mutants in Salmonella typhimurium. Genetics (1973) 2.66

Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of growth in mucus. Infect Immun (1988) 2.65

Relationship between the mouse colonizing ability of a human fecal Escherichia coli strain and its ability to bind a specific mouse colonic mucous gel protein. Infect Immun (1983) 2.61

Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves. Am J Vet Res (1984) 2.60

Transduction by phage P1kc in Salmonella typhimurium. Virology (1974) 2.52

Relation of lipopolysaccharide character to P1 sensitivity in Salmonella typhimurium. Virology (1974) 2.43

Relative colonizing abilities of human fecal and K 12 strains of Escherichia coli in the large intestines of streptomycin-treated mice. Eur J Clin Microbiol (1982) 2.39

Intragenic recombination in a flagellin gene: characterization of the H1-j gene of Salmonella typhi. EMBO J (1989) 2.38

The risk of endothelial infection in adults with salmonella bacteremia. Ann Intern Med (1978) 2.29

Adhesion of a human fecal Escherichia coli strain to mouse colonic mucus. Infect Immun (1985) 2.07

Schedule-induced mirror responding in the pigeon. J Exp Anal Behav (1973) 2.07

Construction of delta aroA his delta pur strains of Salmonella typhi. J Bacteriol (1988) 2.03

The requirement for potassium for bacteriophage T4 protein and deoxyribonucleic acid synthesis. Virology (1965) 1.97

Unique sequences in region VI of the flagellin gene of Salmonella typhi. Mol Microbiol (1989) 1.90

Escherichia coli F-18 and E. coli K-12 eda mutants do not colonize the streptomycin-treated mouse large intestine. Infect Immun (1996) 1.90

Characterization of the heat shock response and identification of heat shock protein antigens of Borrelia burgdorferi. Infect Immun (1990) 1.88

ES18, a general transducing phage for smooth and nonsmooth Salmonella typhimurium. Virology (1970) 1.88

Phase variation of flagellar antigens in Salmonella: abortive transduction studies. J Gen Microbiol (1967) 1.87

Ultraviolet light protection, enhancement of ultraviolet light mutagenesis, and mutator effect of plasmid R46 in Salmonella typhimurium. J Bacteriol (1976) 1.85

Colonization of the mouse intestine by an avirulent Salmonella typhimurium strain and its lipopolysaccharide-defective mutants. Infect Immun (1985) 1.83

Salmonella typhimurium mutants defective in UDP-D-galactose:lipopolysaccharide alpha 1,6-D-galactosyltransferase. Structural, immunochemical, and enzymologic studies of rfaB mutants. J Biol Chem (1983) 1.82

Variation in composition of chromosome fragments transduced by phage P22. Virology (1965) 1.81

An attenuated aroA Salmonella typhimurium vaccine elicits humoral and cellular immunity to cloned beta-galactosidase in mice. J Infect Dis (1987) 1.81

R (transmissible drug-resistance) factors in Salmonella typhimurium: pattern of transduction by phage P22 and ultraviolet-protection effect. J Gen Microbiol (1968) 1.81

Salmonella typhimurium infection in calves: protection and survival of virulent challenge bacteria after immunization with live or inactivated vaccines. Infect Immun (1983) 1.81

Type 1 pili are not necessary for colonization of the streptomycin-treated mouse large intestine by type 1-piliated Escherichia coli F-18 and E. coli K-12. Infect Immun (1989) 1.81

Mapping of rfa Genes in Salmonella typhimurium by ES18 and P22 Transduction and by Conjugation. J Bacteriol (1972) 1.80

Segregation of the mutator property of plasmid R46 from its ultraviolet-protecting property. Mol Gen Genet (1979) 1.79

Infective endocarditis caused by gram-negative bacteria: a review of the literature, 1945-1977. Prog Cardiovasc Dis (1980) 1.75

Role of lipopolysaccharide in colonization of the mouse intestine by Salmonella typhimurium studied by in situ hybridization. Infect Immun (1996) 1.74

Genetics and cultural properties of mutants of Salmonella typhimurium lacking glucosyl or galactosyl lipopolysaccharide transferases. Nature (1968) 1.73

Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counterregulatory mechanism that restrains the immune response. J Exp Med (1997) 1.70

Integration, at hag or elsewhere, of H2 (phase-2 flagellin) genes transduced from Salmonella to Escherichia coli. Genetics (1975) 1.66

A Salmonella typhimurium virulence gene linked to flg. Infect Immun (1989) 1.64

Aromatic-dependent "Salmonella sp." as live vaccine in mice and calves. Dev Biol Stand (1983) 1.64

Genetic aspects of biosynthesis and structure of Salmonella somatic polysaccharide. Ann N Y Acad Sci (1966) 1.64

Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J Exp Med (1996) 1.61

Mutants defective in the 33K outer membrane protein of Salmonella typhimurium. J Bacteriol (1979) 1.60

Aromatic-dependent Salmonella dublin as a parenteral modified live vaccine for calves. Am J Vet Res (1984) 1.54

Genetics of sensitivity of Salmonella species to colicin M and bacteriophages T5, T1, and ES18. J Bacteriol (1977) 1.52

Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of adhesion to mucosal receptors. Infect Immun (1988) 1.51

Mutation of flgM attenuates virulence of Salmonella typhimurium, and mutation of fliA represses the attenuated phenotype. J Bacteriol (1994) 1.51

A key role for type 1 pili in enterobacterial communicability. Mol Microbiol (1992) 1.51

The Escherichia coli K-12 gntP gene allows E. coli F-18 to occupy a distinct nutritional niche in the streptomycin-treated mouse large intestine. Infect Immun (1996) 1.50

A new class of heptose-defective mutant of Salmonella typhimurium. Eur J Biochem (1973) 1.48

Cellular immunity induced by avirulent Salmonella in LPS-defective C3H/HeJ mice. J Immunol (1984) 1.48

Identification and characterization of mouse small intestine mucosal receptors for Escherichia coli K-12(K88ab). Infect Immun (1986) 1.47

Effect of a purA mutation on efficacy of Salmonella live-vaccine vectors. Infect Immun (1989) 1.43

Mono- and bi-phasic Salmonella typhi: genetic homogeneity and distinguishing characteristics. Mol Microbiol (1992) 1.43

Presence of K88-specific receptors in porcine ileal mucus is age dependent. Infect Immun (1990) 1.39

Immunity conferred by Aro- Salmonella live vaccines. Microb Pathog (1991) 1.38

Gene rfaH, which affects lipopolysaccharide core structure in Salmonella typhimurium, is required also for expression of F-factor functions. J Bacteriol (1981) 1.38

Development of an auxotrophic oral live Shigella flexneri vaccine. Vaccine (1988) 1.38

In vivo colonization of the mouse large intestine and in vitro penetration of intestinal mucus by an avirulent smooth strain of Salmonella typhimurium and its lipopolysaccharide-deficient mutant. Infect Immun (1987) 1.36

Genes aroA and serC of Salmonella typhimurium constitute an operon. J Bacteriol (1985) 1.35

Test of the virulence and live-vaccine efficacy of auxotrophic and galE derivatives of Salmonella choleraesuis. Infect Immun (1987) 1.35

Altered colonizing ability for mouse large intestine of a surface mutant of a human faecal isolate of Escherichia coli. J Gen Microbiol (1983) 1.34

Some galE mutants of Salmonella choleraesuis retain virulence. Infect Immun (1986) 1.34

Genetic determination of bacterial virulence, with special reference to Salmonella. Curr Top Microbiol Immunol (1986) 1.34

Salmonella typhimurium mutants of RfaH-phenotype: genetics and antibiotic sensitivities. J Gen Microbiol (1980) 1.32

Isolation and serological analysis of mutant forms of flagellar antigen i of Salmonella typhimurium. J Gen Microbiol (1966) 1.32

Escherichia coli F-18 phase locked 'on' for expression of type 1 fimbriae is a poor colonizer of the streptomycin-treated mouse large intestine. Microb Pathog (1993) 1.30

Comparison of the virulence of O:9,12 and O:4,5,12 Salmonella typhimurium his+ transductants for mice. Infect Immun (1977) 1.30

Suppression of proline requirement of proA and proAB deletion mutants in Salmonella typhimurium by mutation to arginine requirement. J Bacteriol (1969) 1.30

Radiochemical method for evaluating the effect of antibiotics on Escherichia coli biofilms. Antimicrob Agents Chemother (1988) 1.29

Characterization and identification of a porcine small intestine mucus receptor for the K88ab fimbrial adhesin. Infect Immun (1991) 1.28

R-Plasmid Transfer to and from Escherichia coli Strains Isolated from Human Fecal Samples. Appl Environ Microbiol (1981) 1.28

Suppression of amber and ochre mutants in Salmonella typhimurium by a mutant F'-1-gal factor carrying an ochre suppressor gene. J Bacteriol (1969) 1.26

Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen. Vaccine (1996) 1.25

Expression of Escherichia coli F-18 type 1 fimbriae in the streptomycin-treated mouse large intestine. Infect Immun (1991) 1.24